相关实验视频
Updated: Sep 12, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.8K
炭环素诱导的心脏毒性:机制和预防
Edward T H Yeh1, Hui-Ming Chang1
1Little Rock, AR.
概括
拓二聚合酶2b是癌症患者中抗环素诱导的心力衰竭的关键原因. 用德克斯拉佐素向这种酶可以防止心脏毒性,而不会影响化疗的有效性.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 人环素是重要的癌症药物,但会引起剂量依赖的心脏毒性.
- 心肌细胞表达2b拓酶,这与环素诱导的损伤有关.
研究的目的:
- 为了确定特定的拓酶异型调解人环素心脏毒性.
- 评估德克斯拉佐克桑在癌症治疗期间预防心力衰竭的新机制和治疗潜力.
主要方法:
- 利用遗传模型在心肌细胞中删除2b型多poisomerase.
- 研究了人环素对DNA损伤,活性氧物种 (ROS) 和线粒体功能的影响.
- 检查了德克斯拉松对2b拓酶降解的作用.
主要成果:
- 在心肌细胞中删除2b拓素酶可以防止抗环素诱导的DNA损伤,ROS产生,线粒体功能障碍和心力衰竭.
- 德克斯拉松选择性地诱导拓酶2b的降解,节省了拓酶2a.
- 临床前研究支持用德克斯拉松进行预治疗,以减轻心脏毒性.
结论:
- 拓二醇酶2b是环素诱导心脏毒性的关键调解剂.
- 德克斯拉松提供了一种有前途的策略,通过选择性降解2b.topoisomerase来预防心力衰竭.
- 菲尼克斯试验正在研究这种保护性方法.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Heart Failure Drugs: Inotropic Agents
724
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
724
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy IV: Restrictive Cardiomyopathy
31
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31

